Fossat P, Bacqué Cazenave J, De Deurwaerdère P, Cattaert D, Delbecque J. Serotonin, but not dopamine, controls the stress response and anxiety-like behavior in the crayfish Procambarus clarkii. J Exp Biol. 2015;218:2745-52 pubmed publisher

Olianas M, Dedoni S, Onali P. Antidepressants activate the lysophosphatidic acid receptor LPA(1) to induce insulin-like growth factor-I receptor transactivation, stimulation of ERK1/2 signaling and cell proliferation in CHO-K1 fibroblasts. Biochem Pharmacol. 2015;95:311-23 pubmed publisher

Podurgiel S, Milligan M, Yohn S, Purcell L, Contreras Mora H, Correa M, et al. Fluoxetine Administration Exacerbates Oral Tremor and Striatal Dopamine Depletion in a Rodent Pharmacological Model of Parkinsonism. Neuropsychopharmacology. 2015;40:2240-7 pubmed publisher

Okubo M, Murayama N, Miura J, Chiba Y, Yamazaki H. Effects of cytochrome P450 2D6 and 3A5 genotypes and possible coadministered medicines on the metabolic clearance of antidepressant mirtazapine in Japanese patients. Biochem Pharmacol. 2015;93:104-9 pubmed publisher

Dinesh N, Kaur P, Swamy K, Singh S. Mianserin, an antidepressant kills Leishmania donovani by depleting ergosterol levels. Exp Parasitol. 2014;144:84-90 pubmed publisher

Rajpurohit N, Aryal S, Khan M, Stys A, Stys T. Propafenone associated severe central nervous system and cardiovascular toxicity due to mirtazapine: a case of severe drug interaction. S D Med. 2014;67:137-9 pubmed

Yin J, Song J, Lei Y, Xu X, Chen J. Prokinetic effects of mirtazapine on gastrointestinal transit. Am J Physiol Gastrointest Liver Physiol. 2014;306:G796-801 pubmed publisher

Berling I, Isbister G. Mirtazapine overdose is unlikely to cause major toxicity. Clin Toxicol (Phila). 2014;52:20-4 pubmed publisher

Bognár Z, Vonyik G, Gazdag G. [Antidepressant treatment associated hyponatremia -- case report]. Neuropsychopharmacol Hung. 2013;15:177-80 pubmed

Holland J, Bhogle M. Sertraline and mirtazapine as geriatric antidepressants. Psychiatr Danub. 2013;25 Suppl 2:S286-90 pubmed

Liu X, Zhang G, Dong L, Wang X, Sun H, Shen J, et al. Repeated administration of mirtazapine attenuates oxaliplatin-induced mechanical allodynia and spinal NR2B up-regulation in rats. Neurochem Res. 2013;38:1973-9 pubmed publisher

Yosipovitch G, Bernhard J. Clinical practice. Chronic pruritus. N Engl J Med. 2013;368:1625-34 pubmed publisher

Theunissen E, Street D, Højer A, Vermeeren A, van Oers A, Ramaekers J. A randomized trial on the acute and steady-state effects of a new antidepressant, vortioxetine (Lu AA21004), on actual driving and cognition. Clin Pharmacol Ther. 2013;93:493-501 pubmed publisher

Banerjee S, Hellier J, Romeo R, Dewey M, Knapp M, Ballard C, et al. Study of the use of antidepressants for depression in dementia: the HTA-SADD trial--a multicentre, randomised, double-blind, placebo-controlled trial of the clinical effectiveness and cost-effectiveness of sertraline and mirtazapine. Health Technol Assess. 2013;17:1-166 pubmed publisher

Lozano R. Mirtazapine and ondansetron: a dual pharmacodynamic and pharmacokinetic interaction. Afr J Psychiatry (Johannesbg). 2013;16:56 pubmed

Rogóż Z. Effect of co-treatment with mirtazapine and risperidone in animal models of the positive symptoms of schizophrenia in mice. Pharmacol Rep. 2012;64:1567-72 pubmed

Rogóż Z, Kabziński M, Sadaj W, Rachwalska P, Gądek Michalska A. Effect of co-treatment with fluoxetine or mirtazapine and risperidone on the active behaviors and plasma corticosterone concentration in rats subjected to the forced swim test. Pharmacol Rep. 2012;64:1391-9 pubmed

Reed R, Fazel M, Goldring L. [Posttraumatic stress disorder]. Praxis (Bern 1994). 2013;102:45-8 pubmed publisher

Kreiss D, Coffman C, Fiacco N, Granger J, Helton B, Jackson J, et al. Ritualistic chewing behavior induced by mCPP in the rat is an animal model of obsessive compulsive disorder. Pharmacol Biochem Behav. 2013;104:119-24 pubmed publisher

Pae C. Comments on 'what is a rational antidepressant treatment for major depression in patients with Parkinson's disease?'. Psychiatry Clin Neurosci. 2013;67:65-6 pubmed publisher

Raghunath A. Gingival pain: an unusual side effect of ziprasidone. BMJ Case Rep. 2013;2013: pubmed publisher

Gulec M, Oral E, Dursun O, Yucel A, Hacimuftuoglu A, Akcay F, et al. Mirtazapine protects against cisplatin-induced oxidative stress and DNA damage in the rat brain. Psychiatry Clin Neurosci. 2013;67:50-8 pubmed publisher

Schilling C, Gilles M, Blum W, Daseking E, Colla M, Weber Hamann B, et al. Leptin plasma concentrations increase during antidepressant treatment with amitriptyline and mirtazapine, but not paroxetine and venlafaxine: leptin resistance mediated by antihistaminergic activity?. J Clin Psychopharmacol. 2013;33:99-103 pubmed publisher

Zuidersma M, Conradi H, van Melle J, Ormel J, De Jonge P. Depression treatment after myocardial infarction and long-term risk of subsequent cardiovascular events and mortality: a randomized controlled trial. J Psychosom Res. 2013;74:25-30 pubmed publisher

Sagdinc S, Sahinturk A. Molecular structure, FT-IR, FT-Raman, NMR studies and first order molecular hyperpolarizabilities by the DFT method of mirtazapine and its comparison with mianserin. Spectrochim Acta A Mol Biomol Spectrosc. 2013;104:222-34 pubmed publisher

Romeo R, Knapp M, Hellier J, Dewey M, Ballard C, Baldwin R, et al. Cost-effectiveness analyses for mirtazapine and sertraline in dementia: randomised controlled trial. Br J Psychiatry. 2013;202:121-8 pubmed publisher

Bilici M, Cayir K, Tekin S, Gundogdu C, Albayrak A, Suleyman B, et al. Effect of mirtazapine on MNNG-induced gastric adenocarcinoma in rats. Asian Pac J Cancer Prev. 2012;13:4897-900 pubmed

Avena Woods C, Hilas O. Antidepressant use in underweight older adults. Consult Pharm. 2012;27:868-70 pubmed publisher

Knud Larsen J. [Mirtazapine versus other antidepressive agents for depression]. Ugeskr Laeger. 2012;174:2864-6 pubmed

Sfair L, Gobetti C, Sangoi M, Lange A, Steppe M, Schapoval E. Micellar electrokinetic chromatographic method for mianserin hydrochloride and analysis of degradation products by mass spectrometry. Chem Pharm Bull (Tokyo). 2012;60:1387-94 pubmed

Bhasin A, Gurtoo A, Gupta L, Aggarwal G. First case of mirtazepine-induced Stevens-Johnson syndrome from India. Indian J Pharmacol. 2012;44:656-8 pubmed publisher

Kohmura K, Iwamoto K, Aleksic B, Sasada K, Kawano N, Katayama H, et al. Effects of sedative antidepressants on prefrontal cortex activity during verbal fluency task in healthy subjects: a near-infrared spectroscopy study. Psychopharmacology (Berl). 2013;226:75-81 pubmed publisher

Masuzawa M, Taguchi H, Sugimoto T, Kojima H, Matsumoto S, Kojima K, et al. [Case of successful management with mirtazapine for prolonged pain after esophagectomy]. Masui. 2012;61:1003-5 pubmed

Graves S, Rafeyan R, Watts J, Napier T. Mirtazapine, and mirtazapine-like compounds as possible pharmacotherapy for substance abuse disorders: evidence from the bench and the bedside. Pharmacol Ther. 2012;136:343-53 pubmed publisher

Kiblboeck D, Braeuer Mocker M, Siostrzonek P, Reisinger J. A misguided 'pill in the pocket' approach with flecainide leading to cardiac arrest. BMJ Case Rep. 2012;2012: pubmed publisher

Jaquenoud Sirot E, Harenberg S, Vandel P, Lima C, Perrenoud P, Kemmerling K, et al. Multicenter study on the clinical effectiveness, pharmacokinetics, and pharmacogenetics of mirtazapine in depression. J Clin Psychopharmacol. 2012;32:622-9 pubmed

Katsuki A, Yoshimura R, Kishi T, Hori H, Umene Nakano W, Ikenouchi Sugita A, et al. Serum levels of brain-derived neurotrophic factor (BDNF), BDNF gene Val66Met polymorphism, or plasma catecholamine metabolites, and response to mirtazapine in Japanese patients with major depressive disorder (MDD). CNS Spectr. 2012;17:155-63 pubmed publisher

Grubb M, Humphreys W, Josephs J. A semi-automated method for the integrated evaluation of half-life and metabolic soft spots of discovery compounds. Bioanalysis. 2012;4:1747-61 pubmed publisher

Pizzo A, Karam C, Zhang Y, Yano H, Freyberg R, Karam D, et al. The membrane raft protein Flotillin-1 is essential in dopamine neurons for amphetamine-induced behavior in Drosophila. Mol Psychiatry. 2013;18:824-33 pubmed publisher

Yuan J, Johnson R, Huang R, Wichterman J, Jiang H, Hayton K, et al. Genetic mapping of targets mediating differential chemical phenotypes in Plasmodium falciparum. Nat Chem Biol. 2009;5:765-71 pubmed publisher

Diamandis P, Wildenhain J, Clarke I, Sacher A, Graham J, Bellows D, et al. Chemical genetics reveals a complex functional ground state of neural stem cells. Nat Chem Biol. 2007;3:268-73 pubmed

Willins D, Berry S, Alsayegh L, Backstrom J, Sanders Bush E, Friedman L, et al. Clozapine and other 5-hydroxytryptamine-2A receptor antagonists alter the subcellular distribution of 5-hydroxytryptamine-2A receptors in vitro and in vivo. Neuroscience. 1999;91:599-606 pubmed

Lavoie P, Cherradi S, Elie R. Inhibition of K+-induced Ca2+ uptake in rat hippocampus synaptosomes by mianserin enantiomers. Eur J Pharmacol. 1999;369:387-90 pubmed

Harvey J, Welsh S, Hood H, Romano A. Effect of 5-HT2 receptor antagonists on a cranial nerve reflex in the rabbit: evidence for inverse agonism. Psychopharmacology (Berl). 1999;141:162-8 pubmed

de Boer T. The effects of mirtazapine on central noradrenergic and serotonergic neurotransmission. Int Clin Psychopharmacol. 1995;10 Suppl 4:19-23 pubmed

Shimizu M, Nishida A, Fukuda H, Saito H, Yamawaki S. Effects of chronic exposure to desipramine and mianserin on Ca2+ mobilization induced by noradrenaline, acetylcholine, and high K+ in rat frontocortical neurons. Neuropsychobiology. 1996;33:66-70 pubmed

Leitch I, Boura A, King R. Pharmacological evaluation of the histamine H1 and 5-HT blocking properties of 2-N-(carboxamidinonormianserin) (FCC5): in-vitro studies. J Pharm Pharmacol. 1992;44:315-20 pubmed